A team of researchers in the United States has successfully utilized artificial intelligence to design complete genomes for antibacterial bacteriophages. This development marks a technological advancement in the use of computational tools to engineer biological agents capable of targeting specific bacteria.
The application of AI in this field aims to refine the design process of bacteriophages, which are viruses that naturally infect and kill bacteria. By leveraging machine learning to construct these genomes, researchers seek to enhance the efficacy and precision of antibacterial treatments.
In-depth summary · AI, neutral